Drugs / YK-1169
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07634198 | Jun 2026 → Apr 2028 expected | bacterial pneumonia | Nanjing Yoko Biomedical Co., Ltd. | Not yet recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05588531 Comparator | Dec 2021 → Apr 2022 | — | Nanjing Yoko Biomedical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YK-1169 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07634198 ↗ |
| Route | Intravenous | “single intravenous infusion for 2 hours” NCT05588531 ↗ |